Cargando…

Plasma FGF23 levels increase rapidly after acute kidney injury

Emerging evidence suggests that fibroblast growth factor 23 (FGF23) levels are elevated in patients with acute kidney injury (AKI). In order to determine how early this increase occurs we used a murine folic acid nephropathy model and found that plasma FGF23 levels increased significantly from basel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christov, Marta, Waikar, Sushrut, Pereira, Renata, Havasi, Andrea, Leaf, David E., Goltzman, David, Pajevic, Paola Divieti, Wolf, Myles, Jüppner, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766419/ https://www.ncbi.nlm.nih.gov/pubmed/23657144 http://dx.doi.org/10.1038/ki.2013.150

Ejemplares similares

FGF-23: More Than a Regulator of Renal Phosphate Handling?
por: Jüppner, Harald, et al.
Publicado: (2010)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

Recent Progress in Osteocyte Research
por: Divieti Pajevic, Paola
Publicado: (2013)

MON-LB087 Synthesis of Osteocyte-Derived Phosphaturic Hormone FGF23 via IP3/PKC Signaling Downstream of the Extra-Large Gα Subunit (XLαs)
por: He, Qing, et al.
Publicado: (2019)

Osteocyte secreted factors inhibit skeletal muscle differentiation
por: Wood, Charles L., et al.
Publicado: (2017)

Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients
por: Leaf, David E, et al.
Publicado: (2015)

1,25-Dihydroxyvitamin D(3) regulates furin-mediated FGF23 cleavage
por: Xie, Han, et al.
Publicado: (2023)

Impaired Gastric Hormone Regulation of Osteoblasts and Lysyl Oxidase Drives Bone Disease in Diabetes Mellitus
por: Daley, Eileen J, et al.
Publicado: (2019)

Excessive diagnostic testing in acute kidney injury
por: Leaf, David E., et al.
Publicado: (2016)

Impaired 1,25 dihydroxyvitamin D(3) action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH
por: Yuan, Ye, et al.
Publicado: (2021)

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease
por: Dussold, Corey, et al.
Publicado: (2019)

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
por: Grabner, Alexander, et al.
Publicado: (2017)

PTH Protects Osteocytes From Oxidative Stress and Cellular Senescence
por: Uda, Yuhei, et al.
Publicado: (2021)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

Osteocytic FGF23 and Its Kidney Function
por: Agoro, Rafiou, et al.
Publicado: (2020)

Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA Cohort
por: Sunderraj, Ashwin, et al.
Publicado: (2023)

UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE
por: Wolf, Myles
Publicado: (2012)

FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)

FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

Pleiotropic Actions of FGF23
por: Erben, Reinhold G.
Publicado: (2017)

A novel antibody for the detection of alternatively spliced secreted KLOTHO isoform in human plasma
por: Jadhav, Shreyas, et al.
Publicado: (2021)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

Amphiregulin-EGFR Signaling Mediates the Migration of Bone Marrow Mesenchymal Progenitors toward PTH-Stimulated Osteoblasts and Osteocytes
por: Zhu, Ji, et al.
Publicado: (2012)

Protectin DX as a therapeutic strategy against frailty in mice
por: Perazza, Laís R., et al.
Publicado: (2023)

Fibroblast Growth Factor (FGF) 23 Regulates the Plasma Levels of Parathyroid Hormone In Vivo Through the FGF Receptor in Normocalcemia, But Not in Hypocalcemia
por: Mace, Maria L., et al.
Publicado: (2017)

FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia
por: Figurek, Andreja, et al.
Publicado: (2023)

Is there a role in acute kidney injury for FGF23 and Klotho?
por: Mattinzoli, Deborah, et al.
Publicado: (2023)

Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay
por: Schmidt, Insa M., et al.
Publicado: (2022)

FGF23 and Fetuin-A Interaction in the Liver and in the Circulation
por: Mattinzoli, Deborah, et al.
Publicado: (2018)

FGF-23 and sclerostin in serum and bone of CKD patients
por: Lima, Florence, et al.
Publicado: (2023)

FGF23 Producing Mesenchymal Tumor
por: Papierska, Lucyna, et al.
Publicado: (2014)

FGF23 as a calciotropic hormone
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2015)

FGF23 in Acute and Chronic Illness
por: Schnedl, Christian, et al.
Publicado: (2015)

Role of FGF23 in Pediatric Hypercalciuria
por: Moreira Guimarães Penido, Maria Goretti, et al.
Publicado: (2017)

Paracrine Effects of FGF23 on the Heart
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

FGF23, Hypophosphatemia, and Emerging Treatments
por: Imel, Erik A, et al.
Publicado: (2019)

FGF23 and Vitamin D Metabolism
por: Latic, Nejla, et al.
Publicado: (2021)

Uric Acid and Acute Kidney Injury in the Critically Ill
por: Srivastava, Anand, et al.
Publicado: (2019)

Bone marrow and plasma FGF‐23 in heart failure patients: novel insights into the heart–bone axis
por: von Jeinsen, Beatrice, et al.
Publicado: (2019)

Dietary Oxalate Intake and Kidney Outcomes
por: Bargagli, Matteo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6u0v8hr5hktsj40ol07gifftgk